This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) rose 1.11% to $128.99 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index falling 0.74% to 7,553.68 and Dow Jones Industrial Average falling 1.21% to 50,687.07.
The stock's rise snapped a three-day losing streak.
Gilead Sciences Inc. closed 17.99% short of its 52-week high of $157.29, which the company reached on February 11th.
The stock outperformed some of its competitors Wednesday, as Johnson &amp; Johnson (JNJ) rose 0.16% to $223.24, Pfizer Inc. (PFE) fell 0.82% to $25.34, and Abbott Laboratories (ABT) rose 0.02% to $86.99.
Trading volume (6.2 M) eclipsed its 50-day average volume of 6.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-03-26 1636ET

GILD

Gilead Sciences Inc. (GILD) stock rose 1.11% to $128.99, outperforming competitors like Pfizer and Johnson & Johnson during a broader market decline. The gain ended a three-day losing streak, though the stock remains 17.99% below its 52-week high. Trading volume of 6.2 million shares slightly exceeded the 50-day average.

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day